Role of signal-to-cutoff ratios in hepatitis C virus antibody detection

Clinical and Vaccine Immunology

Volumn 19, Issue 8, 2012, Pages 1329-1331

  Moretti, Marco ^a   Pieretti, Barbara ^a   Masucci, Annamaria ^a   Sisti, Davide ^b   Rocchi, Marco ^b   Delprete, Ernesto ^a  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b UNIVERSITY OF URBINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ALGORITHM; ANTIBODY DETECTION; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MEDICAL PARAMETERS; NONHUMAN; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RELIABILITY; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SIGNAL TO CUT OFF RATIO; VALIDATION PROCESS;

CLINICAL LABORATORY TECHNIQUES; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOASSAY;

EID: 84864542145     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00175-12     Document Type: Review

References (17)

1. Brown RS. 2005. Hepatitis C and liver transplantation. Nature 436:973-978.
2. Centers for Disease Control and Prevention. 1991. Public Health Service interagency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C.MMWRMorb. Mortal. Wkly. Rep. 40:1-17.
3. Centers for Disease Control and Prevention. 1998. Recommendations for prevention and control of hepatitis C virus infection and HCV-related chronic disease. MMWR Morb. Mortal. Wkly. Rep. 47:1-53.
4. Centers for Disease Control and Prevention. 2003. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus (anti- HCV). MMWR Morb. Mortal. Wkly. Rep. 52:1-13.
5. Centers for Disease Control and Prevention. 2011. Hepatitis C information for health professionals: laboratory testing. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/hepatitis/HCV/LabTesting.html. Accessed December 2011.
6. Chapko MK, et al. 2005. Cost effectiveness of testing strategies for chronic hepatitis C. Am. J. Gastroenterol. 100:607-615. (Pubitemid 40487560)
7. Chien D, et al. 1992. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc. Natl. Acad. Sci. USA 89:10011-10015.
8. Colin C, et al. 2001. Sensitivity and specificity of third-generation hepatitis C virus antibody detection assay: an analysis of the literature. J. Viral Hepat. 8:87-95. (Pubitemid 32234861)
9. Contreras AM, et al. 2008. Very low hepatitis C antibody levels predict false-positive results and avoid supplemental testing. Transfusion 48: 2540-2548.
10. Deuffic-Burban S, Poyinard T, Sulkowski MS, Wong JB. 2007. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infection in the United States. J. Viral Hepat. 14:107-115. (Pubitemid 46146705)
11. Dufour DR, Talastas M, Fernandez MDA, Harris B. 2003. Chemiluminescence assay improves specificity of hepatitisCantibody detection. Clin. Chem. 49:940-944. (Pubitemid 36623474)
12. Ghany MG, Strader DB, Thomas DL, Seff LB. 2009. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49:1335-1374.
13. Griffith BP, et al. 2003. Hepatitis C virus antibody signal to cut-off ratios predictive of HCV RNA detection: comparison of the Ortho Vitros and EIA assays, abstr M48. Abstr. 19th Annu. Clin. Virol. Symp.
14. Lai KKY, et al. 2011. Improved reflexive testing algorithm for hepatitis C infection using signal-to-cutoff ratios of a hepatitis C virus antibody assay. Clin. Chem. 57:1050-1056.
15. Oethinger M, Mayo DR, Falcone J, Barua PK, Griffith BP. 2005. Efficiency of the Ortho VITROS assay for detection of hepatitis C virusspecific antibodies increased by elimination of supplemental testing of samples with very low sample-to-cutoff ratios. J. Clin. Microbiol. 43: 2477-2480. (Pubitemid 40656272)
16. Van der Poel CL, et al. 1991. Confirmation of hepatitis C virus infection by new four antigen recombinant immunoblot assays. Lancet 337:317-319.
17. World Health Organization. 2002. Gobal alert and response: hepatitis C. World Health Organization, Geneva, Switzerland. www.who.int/csr/disease/ hepatitis/whocdscsrlyo2003/en/index4.html. Accessed December 2011.